Effects of oxybate dose and regimen on disrupted nighttime sleep and sleep architecture: A Plain Language Summary
Year: 2025
Type: article
Abstract: Plain Language SummaryWhat is this summary about?This is a plain language summary of a review article that looked at how different forms of a medicine called oxybate impact sleep in people with narcolepsy. People with narcolepsy often struggle with their sleep. They experience issues like sleep fragmentation or reduced sleep efficiency that may lead to poor sleep quality and disrupted nighttime sleep. To help people with these challenges, oxybate is used to improve sleep and also treat daytime symptoms of narcolepsy (such as excessive daytime sleepiness and cataplexy). Sodium oxybate (SXB; Xyrem®) was first approved in 2002, as a twice-nightly treatment. Newer versions of this medicine have been developed including once-nightly sodium oxybate (ON-SXB; Lumryz™) that contains the same amount of sodium and is taken once per night, and low-sodium oxybate (LXB; Xywav®), which is taken twice per night and has 92% less sodium than SXB. There have not been any direct studies comparing these different oxybate medicines. Information gathered from 5 clinical studies, along with additional supporting research, shows that taking oxybate at night can improve sleep quality and reduce sleep disturbances during the night for people with narcolepsy.How to say (click to play sound)Narcolepsy: NAAR-kuh-lep-seeOxybate: AAK-see-baytWhat were the conclusions?Nighttime sleep patterns are disturbed in people with narcolepsy. Oxybate medicines can improve sleep quality by making deep sleep last longer and reducing sudden wakeups and shifts between sleep stages. These benefits are noticeable whether oxybate is taken once or twice per night. In studies that looked at SXB taken twice nightly, use of the medication tended to show greater improvement in sleep quality later in the night.Sleep fragmentation: Repetitive, short interruptions of sleep or between different sleep stages such as between deep and light sleepSleep efficiency: Time spent asleep as a percent of time spent in bedSleep quality: Can be impacted by the time it takes to fall asleep, how stable different stages of sleep are throughout the night, sleep fragmentation, and sleep efficiency; no single definition has been agreed uponDisrupted nighttime sleep: Usually includes feelings of poor sleep quality, waking up many times during the night, and findings of sleep fragmentation during a sleep study; no single definition has been agreed uponWhat do the conclusions of the study mean?Although no clinical studies have directly compared different oxybate medicines, SXB, ON-SXB, and LXB are effective for improving sleep quality and reducing disturbances at night in people with narcolepsy. Future studies should look at the safety and effectiveness of different oxybate products and dosing regimens (once and twice per night) to better understand their advantages and disadvantages. Comparing these medicines can help doctors choose the best treatment for each person’s needs.Sleep stages: Different types of sleep that are defined based on brain activity. From lightest to deepest sleep, these are N1, N2, and N3. A fourth stage, REM sleep, is when dreaming occurs. Sleep stage shifts refer to the transitions between these stages throughout the nightThis is an abstract of the Plain Language Summary of Publication article.View the full Plain Language Summary PDF of this article to read the full-textLink to original article here
Source: Future Neurology
Institutions: Henry Ford Hospital, Inserm, Université de Montpellier, Hôpital Gui de Chauliac, Institute for Neurosciences of Montpellier, Medical University of South Carolina, University of Modena and Reggio Emilia, Istituto delle Scienze Neurologiche di Bologna, Jazz Pharmaceuticals (United States), Stanford Medicine, Stanford University
Language: English
Subfield: Cognitive Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: diamond
Funder: Jazz Pharmaceuticals
OpenAlex ID: W4409824578
